Se afișează postările cu eticheta Medicines. Afișați toate postările
Se afișează postările cu eticheta Medicines. Afișați toate postările

luni, 12 decembrie 2011

Blood Pressure Medicines Reduce Stroke Risk In People With Prehypertension

Main Category: Hypertension
Also Included In: Stroke
Article Date: 12 Dec 2011 - 0:00 PST

email icon email to a friend   printer icon printer friendly   write icon opinions  
not yet ratednot yet rated
People with prehypertension had a lower risk of stroke when they took blood pressure-lowering medicines, according to research reported in Stroke: Journal of the American Heart Association.

Prehypertension, which affects more than 50 million adults in the United States, is blood pressure ranging between 120/80 mm Hg and 139/89 mm Hg. Hypertension is 140/90 mm Hg or higher.

"Our study pertains to people with pre-hypertensive blood pressure levels and shows that the excess risk of stroke associated with these high-normal readings (top number 120-140) can be altered by taking blood pressure pills," said Ilke Sipahi, M.D., lead author of the study and associate director of Heart Failure and Transplantation at the Harrington-McLaughlin Heart and Vascular Institute in Cleveland, Ohio.

In a meta-analysis of 16 studies, researchers examined data that compared anti-hypertensive drugs against placebo in 70,664 people with average baseline blood pressure levels within the pre-hypertensive range. The researchers found: Patients taking blood pressure-lowering medicines had a 22 percent lower risk of stroke compared to those taking a placebo. This effect was observed across all classes of anti-hypertensive drugs studied. No significant reduction in the risk of heart attack occurred, but there was a trend toward lower cardiovascular death in patients taking blood pressure medications compared to those on placebo. To prevent one stroke in the study population, 169 people had to be treated with a blood pressure-lowering medication for an average 4.3 years. American Heart Association treatment guidelines call for lifestyle changes, not medications, to reduce blood pressure in people with prehypertension. Those lifestyle changes include weight loss, physical activity, a diet rich in fruit and vegetables and low in salt and fat, and keeping alcohol consumption moderate (no more than two drinks per day for men and no more than one drink per day for women).

"We do not think that giving blood pressure medicine instead of implementing the lifestyle changes is the way to go," Sipahi said. "However, the clear-cut reduction in the risk of stroke with blood pressure pills is important and may be complementary to lifestyle changes."

The cost of long-term therapy and the risks associated with blood pressure medicines need to be discussed extensively within the medical community before undertaking guideline changes, Sipahi said.

Co-authors are: Aparna Swaminathan, fourth-year medical student; Viswanath Natesan, M.D.; Sara M. Debanne, Ph.D.; Daniel I. Simon, M.D.; and James C. Fang, M.D. Author disclosures are on the manuscript.

Article adapted by Medical News Today from original press release. Click 'references' tab above for source.
Visit our hypertension section for the latest news on this subject. Statements and conclusions of study authors published in American Heart Association scientific journals are solely those of the study authors and do not necessarily reflect the association's policy or position. The association makes no representation or guarantee as to their accuracy or reliability. The association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific association programs and events. The association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and device corporations are available at www.heart.org/corporatefunding.

American Heart Association

Please use one of the following formats to cite this article in your essay, paper or report:

MLA

American Heart Association. "Blood Pressure Medicines Reduce Stroke Risk In People With Prehypertension." Medical News Today. MediLexicon, Intl., 12 Dec. 2011. Web.
12 Dec. 2011. APA

Please note: If no author information is provided, the source is cited instead.


Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

All opinions are moderated before being included (to stop spam)

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



View the original article here

joi, 8 decembrie 2011

Combating Counterfeit Medicines

Main Category: Pharma Industry / Biotech Industry
Also Included In: Public Health;  Regulatory Affairs / Drug Approvals
Article Date: 08 Dec 2011 - 0:00 PST

email icon email to a friend   printer icon printer friendly   write icon opinions  
not yet ratednot yet rated
In this week's PLoS Medicine, Paul Newton of Mahosot Hospital, Vientiane, Lao PDR and the University of Oxford, UK and colleagues argue that public health issues, and not intellectual property or trade issues, should be the prime consideration in defining and combating counterfeit medicines. They say that the World Health Organization (WHO) should take a more prominent role.

The authors advocate that an international treaty on medicine quality, under the auspices of the WHO, could play a key role in the struggle against counterfeit and substandard medicines.

The authors comment that: "Counterfeit medicines should be defined in terms of harm to health, with punishments appropriate for the injury or killing of patients.

Moreover, it is imperative that public health institutions, ministries, and lawyers, and not primarily IP specialists or industrial and trade bodies, take the strategic lead in countering poor quality medicines."

Article adapted by Medical News Today from original press release. Click 'references' tab above for source.
Visit our pharma industry / biotech industry section for the latest news on this subject. Funding: Wellcome Trust (UK) for PNN & NJW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript, except for the involvement of Chris Bird as an author.
Competing Interests: PN and NJW have scientific collaborations with the Enforcement Working Group of IMPACT, and NJW is co-chair of the WHO malaria treatment guidelines committee but none of the authors have shares in pharmaceutical companies or works as a part of IMPACT. NJW is a member of the PLoS Medicine Editorial Board. The Wellcome Trust had no role in the writing or decision to submit this viewpoint for publication, except for the involvement of CB as an author. BS is co-founder of MPedigree, which is a non-profit based in Ghana that advocates for the development of strategies to fight counterfeiting. All other authors have declared that no competing interests exist.
Citation: Newton PN, Amin AA, Bird C, Passmore P, Dukes G, et al. (2011) The Primacy of Public Health Considerations in Defining Poor Quality Medicines. PLoS Med 8(12): e1001139. doi:10.1371/journal.pmed.1001139
Public Library of Science Please use one of the following formats to cite this article in your essay, paper or report:

MLA

Public Library of Science. "Combating Counterfeit Medicines." Medical News Today. MediLexicon, Intl., 8 Dec. 2011. Web.
8 Dec. 2011. APA

Please note: If no author information is provided, the source is cited instead.


Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

All opinions are moderated before being included (to stop spam)

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



View the original article here